Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

Researchers explored the therapeutic impact of Thiostrepton on experimental colitis by examining its effects on colon inflammation and determining its targets through various biochemical approaches.

Bluebird gets PDUFA date for lovo-cel; FDA lifts hold on DiaMedica stroke trial

The FDA has accepted the BLA from bluebird bio for its gene therapy lovotibeglogene autotemcel, or lovo-cel, designed to treat patients with sickle cell disease

June 22, 2023

New imaging protocol enhances visualization of rare bone marrow cells

Bone marrow plays a crucial role in maintaining hematopoietic stem cells and bone homeostasis. However, research has been hindered by a lack of effective markers

January 21, 2025

FDA approves Avadel’s narcolepsy drug after courts forced Jazz patent delisting

Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma

May 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.